Somaxon Pharma (SOMX) Updates on NDa for Silenor; No Additional Safety or Efficacy Data Required in Resubmission
Tweet Send to a Friend
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) today provided an update on the status of its New Drug Application (NDA) for Silenor ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
